Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fan, Xiao Yang ^a   Chen, Xin You ^b   Liu, Yu Jiao ^a   Zhong, Hui Min ^a   Jiang, Feng Lei ^a   Liu, Yi ^a,b  

^a WUHAN UNIVERSITY   (China)

^b HUBEI ENGINEERING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; CYTOCHROME C; ORGANOARSENIC DERIVATIVE; OXIDE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HL-60 CELL LINE; HUMAN; MCF-7 CELL LINE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PATHOLOGY; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION;

APOPTOSIS; ARSENICALS; CASPASE 3; CELL PROLIFERATION; CYTOCHROMES C; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; OXIDES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84979073410     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29865     Document Type: Article

References (52)

1. Shen, S., Li, X.-F., Cullen, W. R., Weinfeld, M. & Le, X. C. Arsenic binding to proteins. Chem Rev 113, 7769-7792 (2013).
2. Jomova, K. et al. Arsenic: Toxicity, oxidative stress and human disease. J Appl Toxicol 31, 95-107 (2011).
3. Chatterjee, S., Sarkar, S. & Bhattacharya, S. Toxic Metals and Autophagy. Chem Res Toxicol 27, 1887-1900 (2014).
4. Ngu, T. T. & Stillman, M. J. Arsenic binding to human metallothionein. J Am Chem Soc 128, 12473-12483 (2006).
5. Liu, S. et al. Arsenic Induced Overexpression of Inflammatory Cytokines Based on the Human Urothelial Cell Model in Vitro and Urinary Secretion of Individuals Chronically Exposed to Arsenic. Chem Res Toxicol 27, 1934-1942 (2014).
6. Lo-Coco, F. et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. New Engl J Med 369, 112-121 (2013).
7. Coombs, C. C., Tavakkoli, M. & Tallman, M. S. Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer J 5, e304 (2015).
8. Smith, B. R., Eastman, C. M. & Njardarson, J. T. Beyond C, H, O and N! Analysis of the Elemental Composition of US FDA Approved Drug Architectures. J Med Chem 57, 9764-9773 (2014).
9. Jia, P. G. & Huang, X. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspace-3. Chin Med J 114, 19-24 (2001).
10. Evens, A. M., Tallman, M. S. & Gartenhaus, R. B. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leuk Res 28, 891-900 (2004).
11. Eguchi, R. et al. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. J Cell Physiol 226, 762-768 (2011).
12. Oketani, M. et al. Inhibition by arsenic trioxide of human hepatoma cell growth. Cancer Lett 183, 147-153 (2002).
13. Waxman, S. & Anderson, K. C. History of the development of arsenic derivatives in cancer therapy. Oncologist 6 Suppl 2, 3-10 (2001).
14. Dilda, P. J. & Hogg, P. J. Arsenical-based cancer drugs. Cancer Treat Rev 33, 542-564 (2007).
15. Liu, Y. et al. Dithiaarsanes inducing oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting the thioredoxin reductase. J Med Chem 57, 5203-5211 (2014).
16. Thompson, R. C. & Smith, D. C. Evaluation of the treatment of early syphilis with arsphenamine and heavy metal. Am J Syph Gonorrhea Vener Dis 34, 410-419 (1950).
17. Galluzzi, L. et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19, 107-120 (2011).
18. Reed, J. C. Mechanisms of apoptosis. Am J Pathol 157, 1415-1430 (2000).
19. Strasser, A., Oconnor, L. & Dixit, V. M. Apoptosis signaling. Annu Rev Biochem 69, 217-245 (2000).
20. Callista, Y., Wen, Y. & Siegfried, H. The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans. Cell 157, 897-909 (2014).
21. Chipuk, J. & Green, D. Dissecting p53-dependent apoptosis. Cell Death Differ 13, 994-1002 (2006).
22. Kang, J. M. et al. Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol 299, G1147-G1153 (2010).
23. Zamora, P. L., Rockenbauer, A. & Villamena, F. A. Radical Model of Arsenic (III) Toxicity: Theoretical and EPR Spin Trapping Studies. Chem Res Toxicol 27, 765-774 (2014).
24. Slyemi, D. & Bonnefoy, V. How prokaryotes deal with arsenic. Environ Microbiol Rep 4, 571-586 (2012).
25. Indran, I. R., Hande, M. P. & Pervaiz, S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 71, 266-276 (2011).
26. Navarro, R., Busnadiego, I., Ruiz-Larrea, M. B. & Ruiz-Sanz, J. I. Superoxide Anions Are Involved in Doxorubicin-Induced ERK Activation in Hepatocyte Cultures. Ann N Y Acad Sci 1090, 419-428 (2006).
27. Duan, D., Zhang, B., Yao, J., Liu, Y. & Fang, J. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells. Free Radic Biol Med 70, 182-193 (2014).
28. Simon, H.-U., Haj-Yehia, A. & Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418 (2000).
29. da Silva, C. M. et al. Schiff bases: A short review of their antimicrobial activities. J Adv Res 2, 1-8 (2011).
30. Yanhua, Z. et al. Arsenic trioxide (As(2)O(3)) induces apoptosis through activation of Bax in hematopoietic cells. Oncogene 24, 3339-3347 (2005).
31. Rocha, R. A. et al. Arsenic and fluoride induce neural progenitor cell apoptosis. Toxicol Lett 203, 237-244 (2011).
32. Zhang, Y. et al. Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a. Neoplasma 60, 247-253 (2013).
33. Yen, Y. P. et al. Arsenic induces apoptosis in myoblasts through a reactive oxygen species-induced endoplasmic reticulum stress and mitochondrial dysfunction pathway. Arch Toxicol 86, 923-933 (2012).
34. Cheng, Y. et al. Neuroprotective effect of resveratrol on arsenic trioxide-induced oxidative stress in feline brain. Hum Exp Toxicol 33, 737-747 (2014).
35. Piga, R., Saito, Y., Yoshida, Y. & Niki, E. Cytotoxic effects of various stressors on PC12 cells: involvement of oxidative stress and effect of antioxidants. Neurotoxicology 28, 67-75 (2007).
36. Li, J.-j. et al. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin 27, 1078-1084 (2006).
37. Hu, X.-M., Hirano, T. & Oka, K. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Cancer Chemother Pharmacol 52, 47-58 (2003).
38. Shapiro, H. M. Membrane potential estimation by flow cytometry. Methods 21, 271-279 (2000).
39. Spuches, A. M., Kruszyna, H. G., Rich, A. M. & Wilcox, D. E. Thermodynamics of the As(III)-thiol interaction: Arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. Inorg Chem 44, 2964-2972 (2005).
40. Gregory, C. D. & Pound, J. D. Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis 15, 1029-1049 (2010).
41. Giansanti, V., Torriglia, A. & Scovassi, A. I. Conversation between apoptosis and autophagy: "Is it your turn or mine?". Apoptosis 16, 321-333 (2011).
42. Chen, C., Jiang, X., Ren, Y. & Zhang, Z. Arsenic trioxide co-exposure potentiates benzo (a) pyrene genotoxicity by enhancing the oxidative stress in human lung adenocarcinoma cell. Biol Trace Elem Res 156, 338-349 (2013).
43. Circu, M. L. & Aw, T. Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48, 749-762 (2010).
44. Husain, K., Whitworth, C. & Rybak, L. P. Time response of carboplatin-induced nephrotoxicity in rats. Pharmacol Res 50, 291-300 (2004).
45. Jia, P. et al. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Chin Med J 114, 19-24 (2001).
46. Skommer, J., Brittain, T. & Raychaudhuri, S. Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cell-to-cell variations in the mitochondrial pathway of cell death. Apoptosis 15, 1223-1233 (2010).
47. Martinou, J.-C. & Youle, R. J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21, 92-101 (2011).
48. Iguchi, K., Hirano, K. & Ishida, R. Activation of caspase-3, proteolytic cleavage of DFF and no oligonucleosomal DNA fragmentation in apoptotic Molt-4 cells. J Biochem 131, 469-475 (2002).
49. Zhu, X.-F. et al. Involvement of caspase-3 activation in squamocin-induced apoptosis in leukemia cell line HL-60. Life Sci 70, 1259-1269 (2002).
50. Carambula, S. F. et al. Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum. Endocrinology 143, 1495-1501 (2002).
51. Brentnall, M., Rodriguez-Menocal, L., De Guevara, R. L., Cepero, E. & Boise, L. H. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 14, 32 (2013).
52. Wilson, P. et al. Organic arsenicals as efficient and highly specific linkers for protein/peptide-polymer conjugation. J Am Chem Soc 137, 4215-4222 (2015).